Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Excision BioTherapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11073
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Excision BioTherapeutics Inc (Excision BioTherapeutics) is a developer of gene editing therapeutics for the treatment of infectious diseases. The company’s products comprise EBT101, a HIV CRISPR Cas9 gRNA multiplex biologic for the prevention of Human Immunodeficiency Virus; EBT103, a PML JCV CRISPR Cas9 gRNA T-antigen biologic for the treatment of progressive multifocal leukoencephalopathy; EBT104, a HSV CRISPR Cas9 gRNA ICP biologic for targeting herpes simplex virus; CRISPR vaccinations and advanced DNA and biologic delivery systems. The company develops gene editing tools on ViraSuite technology platform to eradicate viral related diseases from human patients. Excision BioTherapeutics is headquartered in Philadelphia, Pennsylvania, the US.

Excision BioTherapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Excision BioTherapeutics Raises USD10 Million in Seed Financing 10
Licensing Agreements 11
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 11
Excision BioTherapeutics Enters into Licensing Agreement with Temple University 12
Excision BioTherapeutics Inc – Key Competitors 13
Excision BioTherapeutics Inc – Key Employees 14
Excision BioTherapeutics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Excision BioTherapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Excision BioTherapeutics Raises USD10 Million in Seed Financing 10
Excision BioTherapeutics Enters into Licensing Agreement with University of California Berkeley 11
Excision BioTherapeutics Enters into Licensing Agreement with Temple University 12
Excision BioTherapeutics Inc, Key Competitors 13
Excision BioTherapeutics Inc, Key Employees 14

List of Figures
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Excision BioTherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Excision BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bacardi Limited:企業の戦略・SWOT・財務情報
    Bacardi Limited - Strategy, SWOT and Corporate Finance Report Summary Bacardi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Aeon Global Health Corp (ADAT):医療機器:M&Aディール及び事業提携情報
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp, is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory service …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Catholic Health Initiatives:企業のM&A・事業提携・投資動向
    Catholic Health Initiatives - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catholic Health Initiatives Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Aibel AS:企業の戦略的SWOT分析
    Aibel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • The Hong Kong Jockey Club:企業の戦略的SWOT分析
    The Hong Kong Jockey Club - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Cooper Tire & Rubber Company:企業の戦略・SWOT・財務分析
    Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Massarella Catering Group Ltd. :企業の戦略・SWOT・財務情報
    Massarella Catering Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Massarella Catering Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Riot Blockchain Inc (RIOT):医療機器:M&Aディール及び事業提携情報
    Summary Riot Blockchain Inc (Riot Blockchain) builds, operates and supports blockchain technologies. Its primary operations include mining of cryptocurrencies and development of exchange and mining pool platforms. The company focuses on both Bitcoin and Ethereum blockchain ecosystems. Riot Blockchai …
  • MetGen Oy:製薬・医療:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • Kemwell Biopharma Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd, a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentr …
  • Mustek Ltd (MST):企業の財務・戦略的SWOT分析
    Mustek Ltd (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MediaValet Inc.:戦略・SWOT・企業財務分析
    MediaValet Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaValet Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Eaton Corporation Plc (ETN):企業の財務・戦略的SWOT分析
    Eaton Corporation Plc (ETN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Snowy Hydro Ltd-エネルギー分野:企業M&A・提携分析
    Summary Snowy Hydro Limited (Snowy Hydro) is an integrated energy utility that generates, supplies, trades, and retails electricity. The company produces power from gas and hydro sources. It owns and operates gas plants: Valley Power, Laverton North, and Colongra; and Snowy Mountains Scheme hydroele …
  • Reliance Insurance Limited:企業の戦略・SWOT・財務情報
    Reliance Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Gordon Food Service Inc:企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cost Plus Inc:企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆